Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions
Condition(s) studied
Investigational drug(s) / intervention(s)
Influenza vaccination: Influenza vaccination pre-discharge in patients hospitalized for acute cardiac conditions
Study summary
Patients hospitalized for acute cardiac conditions-including acute myocardial infarction, acute heart failure, pulmonary embolism, arrhythmias, and hypertensive emergencies-represent a heterogeneous population at very high risk of recurrent cardiovascular events. Influenza infection may act as a trigger for adverse cardiovascular events. Given the persistently low influenza vaccination uptake despite evidence-based benefits observed in vulnerable populations, including patients with cardiac conditions, new strategies to improve vaccination coverage are being explored. Recently, increasing attention has been directed toward an approach already used in fields such as neonatology, where vaccinations are administered prior to hospital discharge.
In this investigator-initiated, single-center, randomized, open-label interventional study, we will evaluate whether influenza vaccination administered within 24 hours before hospital discharge in patients hospitalized for acute cardiac conditions is safe and effective in reducing subsequent infections, cardiovascular events, and mortality during the 6 months following hospitalization.
Eligibility
Primary outcome measure(s)
- infection, unplanned cardiovascular hospitalization or cardiovascular death — 6 months
For the purposes of the study, infection was defined as an acute illness characterized by at least one of the following symptoms or events: * typical symptoms (malaise, fatigue, etc.), * self-measured body temperature of 38°C or higher, * the need for antipyretic / analgesic medication, * medical consultation (e.g. with general practitioner) due to infection, * unplanned hospitalization due to infection.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Jan Mikulicz Radecki University Hospital in Wroclaw | Wroclaw | Poland | Recruiting |
More Wroclaw Medical University trials in Poland
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07617376 on ClinicalTrials.gov ↗ ← All trials in Poland